抗狂犬病血清の世界市場レポート 2025年

抗狂犬病血清市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.4％で18億5,000万米ドルに成長します。予測期間の成長は、動物による咬傷の発生率の上昇、狂犬病研究への資金提供の増加、人獣共通感染症に対する意識の高まり、血清の保存と取り扱いの改善、狂犬病対策プログラムへの支援の強化などに起因しています。予測期間における主な動向としては、新しい血清製剤の開発、ヘルスケアインフラの進歩、血清製造の技術的進歩、代替送達システムの開発、迅速診断キットの開発などが挙げられます。

犬による咬傷の発生率の増加は、抗狂犬病血清市場の拡大を促進すると予想されます。犬による咬傷は、軽微な擦り傷から重傷まで様々であり、感染症や狂犬病のような疾患の潜在的伝播など、重大な健康リスクをもたらします。これらのリスクを管理するためには、効果的な予防と迅速な治療が不可欠です。犬による咬傷の頻度が増加しているのは、都市化によって人と犬との交流が増えたこと、しつけのなっていない犬やしつけの不十分な犬が増えたこと、犬の行動や咬傷予防に関する認識や教育が不足していることなどが原因です。その結果、犬による咬傷の有病率の増加が抗狂犬病血清の需要を押し上げています。狂犬病に感染している可能性のある動物に接触した場合、狂犬病の発症を予防するためには適時の投与が不可欠だからです。例えば、2023年に米国獣医師会が報告したところによると、犬による咬傷の保険金請求にかかる平均費用は5万8,545米ドルで、保険会社は犬による咬傷やその他の犬に関連する怪我に関連する賠償請求に11億2,000万米ドルを支払っています。犬の咬傷による賠償請求は2023年に10％近く増加し、抗狂犬病血清に対する需要の高まりを浮き彫りにしています。

抗狂犬病血清市場の主要企業は、製品開発を強化し市場開拓の幅を広げるために戦略的パートナーシップを結んでいます。戦略的パートナーシップとは、各社の強みとリソースを活用し、相互の利益と成功を達成することです。例えば、米国に本社を置くバイオ医薬品会社Kedrion S.p.A.は、2023年7月にイスラエルのバイオ医薬品会社Kamadaと提携し、KEDRAB（狂犬病免疫グロブリン［ヒト］）を米国で販売することになりました。この協力関係は、米国における製品の共同開発およびライセンシングにおいて極めて重要であると同時に、この病気に対する認識を広める上でも重要でした。両社の共同努力は、狂犬病動物に咬まれた人々を、重篤で生命を脅かす可能性のある状態から守ることに貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界抗狂犬病血清PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の抗狂犬病血清市場：成長率分析
• 世界の抗狂犬病血清市場の実績：規模と成長, 2019-2024
• 世界の抗狂犬病血清市場の予測：規模と成長, 2024-2029, 2034F
• 世界抗狂犬病血清総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の抗狂犬病血清市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒト抗狂犬病免疫グロブリン
• 馬用狂犬病免疫グロブリン
• 世界の抗狂犬病血清市場用量と剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイアル
• プレフィルドシリンジ
• 世界の抗狂犬病血清市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈内
• 筋肉内
• 世界の抗狂犬病血清市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 動物病院
• 世界の抗狂犬病血清市場、ヒト抗狂犬病免疫グロブリンのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一価ヒト抗狂犬病免疫グロブリン
• 多価ヒト抗狂犬病免疫グロブリン
• 筋肉内投与ヒト抗狂犬病免疫グロブリン
• 静脈内ヒト抗狂犬病免疫グロブリン
• 凍結乾燥ヒト抗狂犬病免疫グロブリン
• 世界の抗狂犬病血清市場馬用抗狂犬病免疫グロブリンのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 凍結乾燥馬用狂犬病免疫グロブリン
• 液体馬用狂犬病免疫グロブリン
• 一価馬抗狂犬病免疫グロブリン
• 多価馬抗狂犬病免疫グロブリン

第7章 地域別・国別分析

• 世界の抗狂犬病血清市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の抗狂犬病血清市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗狂犬病血清市場：競合情勢
• 抗狂犬病血清市場：企業プロファイル
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • HCX Pharmaceuticals LLP Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Intas Pharmaceuticals Ltd
• Bavarian Nordic AS
• Serum Institute of India Pvt Ltd.
• Bharat Serums And Vaccines Limited
• Indian Immunologicals Ltd.
• Bharat Biotech.
• National Institute of Health Islamabad
• ViNS Bioproducts Ltd.
• Shanghai Serum Bio-technology
• Premium Serums and Vaccines Pvt Ltd.
• Congruent Pharmachem
• Haffkine Bio Pharmaceutical Corporation Limited
• LEXICARE PHARMA PVT. LTD.
• Avin Darou
• Central Research Institute Kasauli

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 抗狂犬病血清市場2029：新たな機会を提供する国
• 抗狂犬病血清市場2029：新たな機会を提供するセグメント
• 抗狂犬病血清市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Anti-rabies serum, also known as rabies immune globulin (RIG), is a medical treatment that provides immediate passive immunity against the rabies virus. It is used for individuals exposed to the virus, typically through bites or scratches from potentially rabid animals, and is administered alongside the rabies vaccine. The serum contains antibodies that neutralize the virus, helping to prevent the development of rabies, a fatal disease once symptoms appear.

The main types of anti-rabies serum are human anti-rabies immunoglobulin and equine anti-rabies immunoglobulin. Human rabies immune globulin (HRIG) is derived from the blood plasma of human donors who have been immunized against rabies and is preferred for its lower risk of allergic reactions and better compatibility with human patients. This serum is available in various dosage forms, including vials and prefilled syringes, and is administered either intravenously or intramuscularly. It is used by a range of end-users, including hospitals, clinics, and veterinary hospitals.

The anti-rabies serum market research report is one of a series of new reports from The Business Research Company that provides anti-rabies serum market statistics, including anti-rabies serum industry global market size, regional shares, competitors with a anti-rabies serum market share, detailed anti-rabies serum market segments, market trends and opportunities, and any further data you may need to thrive in the anti-rabies serum industry. This anti-rabies serum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-rabies serum market size has grown strongly in recent years. It will grow from $1.42 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to growth in animal populations, expansion of vaccination programs, improved diagnostic techniques, increased travel and migration, and rising public health initiatives, rising incidence of wildlife encounters.

The anti-rabies serum market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the rising incidence of animal bites, increased funding for rabies research, rising awareness of zoonotic diseases, improvement in serum storage and handling, and enhanced support for rabies control programs. Major trends in the forecast period include the development of new serum formulations, advancements in healthcare infrastructure, technological advancements in serum production, the development of alternative delivery systems, and the development of rapid diagnostic kits.

The growing incidence of dog bites is expected to drive the expansion of the anti-rabies serum market. Dog bites, which can range from minor scratches to severe injuries, pose significant health risks including infections and the potential transmission of diseases such as rabies. Effective prevention and prompt medical treatment are crucial for managing these risks. The increasing frequency of dog bites is attributed to factors such as urbanization, which leads to more interactions between people and dogs, a higher number of unrestrained or poorly trained dogs, and a lack of awareness or education about dog behavior and bite prevention. Consequently, the rising prevalence of dog bites has boosted the demand for anti-rabies serum, as timely administration is essential to prevent the onset of rabies in those exposed to potentially infected animals. For example, in 2023, the American Veterinary Medical Association reported that the average cost for dog bite insurance claims was $58,545, with insurers paying out $1.12 billion in liability claims related to dog bites and other dog-related injuries. Dog bite claims increased by nearly 10% in 2023, highlighting the growing demand for anti-rabies serum.

Major companies in the anti-rabies serum market are forming strategic partnerships to enhance product development and broaden their market reach. Strategic partnerships involve leveraging each company's strengths and resources to achieve mutual benefits and success. For example, in July 2023, Kedrion S.p.A, a biopharmaceutical company based in the US, partnered with Kamada, an Israeli biopharmaceutical firm, to distribute KEDRAB (Rabies Immune Globulin [Human]) in the United States. This collaboration has been crucial in co-developing and licensing the product in the U.S. while also promoting awareness of the disease. Their joint efforts have contributed to protecting individuals exposed to rabid animal bites from serious and potentially life-threatening conditions.

In May 2022, Ceva Sante Animale, a French veterinary pharmaceutical company, acquired Artemis Technologies Inc. for an undisclosed amount. This acquisition enhances Ceva's rabies portfolio and strengthens its market presence in North America. Artemis Technologies Inc., based in Canada, provides a rabies glycoprotein recombinant oral vaccine.

Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals

North America was the largest region in the anti-rabies serum market in 2024. The regions covered in the anti-rabies serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti-rabies serum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-rabies serum market consists of sales of rabies monoclonal antibodies, rabies immune globulin (RIG) combination products, and human rabies immune globulin (HRIG). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Rabies Serum Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-rabies serum market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-rabies serum ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-rabies serum market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Human Anti-rabies Immunoglobulin; Equine Anti-rabies Immunoglobulin
• 2) By Dosage And Form: Vials; Prefilled Syringes
• 3) By Route of Administration: Intravenous; Intramuscular
• 4) By End User: Hospitals; Clinics; Veterinary Hospitals
• Subsegments:
• 1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin; Polyvalent Human Anti-Rabies Immunoglobulin; Intramuscular Human Anti-Rabies Immunoglobulin; Intravenous Human Anti-Rabies Immunoglobulin; Freeze-Dried Human Anti-Rabies Immunoglobulin
• 2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin; Liquid Equine Anti-Rabies Immunoglobulin; Monovalent Equine Anti-Rabies Immunoglobulin; Polyvalent Equine Anti-Rabies Immunoglobulin
• Companies Mentioned: Merck & Co Inc.; Sanofi SA; GlaxoSmithKline PLC; Takeda Pharmaceutical Company Limited; HCX Pharmaceuticals LLP
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anti-Rabies Serum Market Characteristics

3. Anti-Rabies Serum Market Trends And Strategies

4. Anti-Rabies Serum Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Anti-Rabies Serum Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anti-Rabies Serum PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anti-Rabies Serum Market Growth Rate Analysis
• 5.4. Global Anti-Rabies Serum Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anti-Rabies Serum Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anti-Rabies Serum Total Addressable Market (TAM)

6. Anti-Rabies Serum Market Segmentation

• 6.1. Global Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Anti-rabies Immunoglobulin
• Equine Anti-rabies Immunoglobulin
• 6.2. Global Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vials
• Prefilled Syringes
• 6.3. Global Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous
• Intramuscular
• 6.4. Global Anti-Rabies Serum Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Veterinary Hospitals
• 6.5. Global Anti-Rabies Serum Market, Sub-Segmentation Of Human Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monovalent Human Anti-Rabies Immunoglobulin
• Polyvalent Human Anti-Rabies Immunoglobulin
• Intramuscular Human Anti-Rabies Immunoglobulin
• Intravenous Human Anti-Rabies Immunoglobulin
• Freeze-Dried Human Anti-Rabies Immunoglobulin
• 6.6. Global Anti-Rabies Serum Market, Sub-Segmentation Of Equine Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Freeze-Dried Equine Anti-Rabies Immunoglobulin
• Liquid Equine Anti-Rabies Immunoglobulin
• Monovalent Equine Anti-Rabies Immunoglobulin
• Polyvalent Equine Anti-Rabies Immunoglobulin

7. Anti-Rabies Serum Market Regional And Country Analysis

• 7.1. Global Anti-Rabies Serum Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anti-Rabies Serum Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti-Rabies Serum Market

• 8.1. Asia-Pacific Anti-Rabies Serum Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti-Rabies Serum Market

• 9.1. China Anti-Rabies Serum Market Overview
• 9.2. China Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti-Rabies Serum Market

• 10.1. India Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti-Rabies Serum Market

• 11.1. Japan Anti-Rabies Serum Market Overview
• 11.2. Japan Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti-Rabies Serum Market

• 12.1. Australia Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti-Rabies Serum Market

• 13.1. Indonesia Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti-Rabies Serum Market

• 14.1. South Korea Anti-Rabies Serum Market Overview
• 14.2. South Korea Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti-Rabies Serum Market

• 15.1. Western Europe Anti-Rabies Serum Market Overview
• 15.2. Western Europe Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti-Rabies Serum Market

• 16.1. UK Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti-Rabies Serum Market

• 17.1. Germany Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti-Rabies Serum Market

• 18.1. France Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti-Rabies Serum Market

• 19.1. Italy Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti-Rabies Serum Market

• 20.1. Spain Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti-Rabies Serum Market

• 21.1. Eastern Europe Anti-Rabies Serum Market Overview
• 21.2. Eastern Europe Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti-Rabies Serum Market

• 22.1. Russia Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti-Rabies Serum Market

• 23.1. North America Anti-Rabies Serum Market Overview
• 23.2. North America Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti-Rabies Serum Market

• 24.1. USA Anti-Rabies Serum Market Overview
• 24.2. USA Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti-Rabies Serum Market

• 25.1. Canada Anti-Rabies Serum Market Overview
• 25.2. Canada Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti-Rabies Serum Market

• 26.1. South America Anti-Rabies Serum Market Overview
• 26.2. South America Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti-Rabies Serum Market

• 27.1. Brazil Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti-Rabies Serum Market

• 28.1. Middle East Anti-Rabies Serum Market Overview
• 28.2. Middle East Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti-Rabies Serum Market

• 29.1. Africa Anti-Rabies Serum Market Overview
• 29.2. Africa Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti-Rabies Serum Market Competitive Landscape And Company Profiles

• 30.1. Anti-Rabies Serum Market Competitive Landscape
• 30.2. Anti-Rabies Serum Market Company Profiles
  • 30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. HCX Pharmaceuticals LLP Overview, Products and Services, Strategy and Financial Analysis

31. Anti-Rabies Serum Market Other Major And Innovative Companies

• 31.1. Intas Pharmaceuticals Ltd
• 31.2. Bavarian Nordic AS
• 31.3. Serum Institute of India Pvt Ltd.
• 31.4. Bharat Serums And Vaccines Limited
• 31.5. Indian Immunologicals Ltd.
• 31.6. Bharat Biotech.
• 31.7. National Institute of Health Islamabad
• 31.8. ViNS Bioproducts Ltd.
• 31.9. Shanghai Serum Bio-technology
• 31.10. Premium Serums and Vaccines Pvt Ltd.
• 31.11. Congruent Pharmachem
• 31.12. Haffkine Bio Pharmaceutical Corporation Limited
• 31.13. LEXICARE PHARMA PVT. LTD.
• 31.14. Avin Darou
• 31.15. Central Research Institute Kasauli

32. Global Anti-Rabies Serum Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti-Rabies Serum Market

34. Recent Developments In The Anti-Rabies Serum Market

35. Anti-Rabies Serum Market High Potential Countries, Segments and Strategies

• 35.1 Anti-Rabies Serum Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anti-Rabies Serum Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anti-Rabies Serum Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33398_Anti_Rabies_Serum_GMR_2025